490 related articles for article (PubMed ID: 6602846)
1. The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
[TBL] [Abstract][Full Text] [Related]
2. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
3. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
4. B cell growth-promoting activity of recombinant human interleukin 4.
Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
6. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
Jelinek DF; Lipsky PE
J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
[TBL] [Abstract][Full Text] [Related]
7. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
Kehrl JH; Muraguchi A; Fauci AS
Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
9. T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
Thompson CB; Schaefer ME; Finkelman FD; Scher I; Farrar J; Mond JJ
J Immunol; 1985 Jan; 134(1):369-74. PubMed ID: 3917279
[TBL] [Abstract][Full Text] [Related]
10. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS
J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603
[TBL] [Abstract][Full Text] [Related]
11. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
12. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
Suzuki T; Butler JL; Cooper MD
J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS
J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179
[TBL] [Abstract][Full Text] [Related]
14. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P
J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
[TBL] [Abstract][Full Text] [Related]
16. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
Baluyut AR; Subbarao B
J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
[TBL] [Abstract][Full Text] [Related]
17. Functional properties of two human B cell growth factor species separated by lectin affinity column.
Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
[TBL] [Abstract][Full Text] [Related]
18. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
[TBL] [Abstract][Full Text] [Related]
19. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
20. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
Muraguchi A; Kehrl JH; Butler JL; Fauci AS
J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]